Clinical Trials Logo

Chronic Heart Failure clinical trials

View clinical trials related to Chronic Heart Failure.

Filter by:

NCT ID: NCT01886391 Withdrawn - Clinical trials for Chronic Heart Failure

Health Behavior-Related Outcomes With Diaphragmatic Breathing Retraining in Heart Failure Patients

Start date: November 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to provide information on how the practicing of deep breathing ("DBR" - diaphragmatic breathing re-training) may improve the health outcomes and likelihood of heart failure patients to engage in health-promoting activities by successfully controlling their shortness of breath (dyspnea).

NCT ID: NCT01878630 Completed - Clinical trials for Chronic Heart Failure

Telemedical Interventional Management in Heart Failure II

TIM-HF2
Start date: August 8, 2013
Phase: Phase 3
Study type: Interventional

Superiority of additional Remote Patient Management (RPM) in patients with chronic heart failure (CHF) in comparison to usual care in terms of, e.g.: - days lost due to unplanned cardiovascular hospitalization or death - all-cause mortality - cardiovascular mortality - quality of life

NCT ID: NCT01864733 Not yet recruiting - Clinical trials for Chronic Heart Failure

Multimodal Approach of Undernutrition in Chronic Heart Failure

NUTRICARD
Start date: May 2013
Phase: N/A
Study type: Interventional

The treatment of chronic heart failure (CHF) is a key challenge in public health. Despite medical advances, 1-year mortality of NYHA III-IV CHF is 28%. Undernutrition is an independent risk factor for mortality and complications. Up-to-date, interventional studies involving nutrition are scarce in CHF. Academic societies are recommending the use of oral nutritional supplements (ONS) in case of weight loss, without defining the modalities. ONS could improve nutritional status in undernourished CHF patients, but solely administered, have a limited impact on undernutrition, physical performance and prognosis. A multimodal approach integrating physical exercise, nutritional intakes, polyunsaturated n-3 fatty acids (n-3 PUFA), and anabolizing hormones, has to be privileged. A recent trial has shown the clinical benefits of such an approach in patients with chronic respiratory insufficiency (CRI), who have similar nutritional and muscular characteristics. Exercise rehabilitation is well validated in CHF patients, but has never been validated in case of undernutrition. Exercise rehabilitation allows improving exercise capacity, quality of life and cardiovascular outcomes including mortality. N-3 PUFA supplementation improves muscle strength and endurance in CRI patients. n-3 PUFA supplementation decreases by 30% cardiovascular mortality of CHF patients. n-3 PUFA could be useful for CHF patients rehabilitation. Androgenopenia is a prognostic factor in CHF. Androgen substitution improves significantly muscle strength, walking endurance and quality of life. In the context of a multimodal approach, Androgen substitution together with exercise rehabilitation and ONS could have a beneficial effect on muscle mass, strength and endurance of CHF patients, as already described in CRI, elderly and HIV patients. The study hypotheses that a 3-month multimodal approach associating exercise rehabilitation, androgen substitution, n-3 PUFAs and ONS improves exercise capacity of undernourished CHF patients.

NCT ID: NCT01855165 Recruiting - Clinical trials for Chronic Heart Failure

The Role of Clinical Pharmacist in Management of DDIs in CHF Patients

Start date: April 2013
Phase: N/A
Study type: Interventional

Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their condition. Data bases often detect DDIs that are of high clinical relevance. The investigators have performed this study in order to detect clinically significant DDIs and to diminish their occurrence by sending notification about DDIs to attending physician.

NCT ID: NCT01831128 Completed - Clinical trials for Chronic Heart Failure

French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS)

FACE
Start date: November 2009
Phase:
Study type: Observational

The purpose of FACE study is to provide in routine practice complementary long-term data on the mortality and morbidity of Chronic Heart Failure (CHF) patients with Central Sleep Apnea eligible for Adaptative Servo-Ventilation (ASV) treatment (PaceWave, AutoSet CS; ResMed).

NCT ID: NCT01829880 Recruiting - Clinical trials for Chronic Heart Failure

Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure

Start date: October 2011
Phase: N/A
Study type: Observational

The purpose of this study is to determine if cachexia and changes in body composition influence pharmacokinetics of bisoprolol and ramipril and the accuracy of equations for renal function estimation.

NCT ID: NCT01813331 Completed - Clinical trials for Chronic Heart Failure

ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure

ALERT-HF
Start date: November 2012
Phase: N/A
Study type: Observational [Patient Registry]

ALERT-HF is an observational study aimed to evaluate the diagnostic criteria adopted and the adherence to the current therapeutic guidelines in a large series of patients affected with chronic heart failure. Secondary objective is to evaluate the prevalence of chronic heart failure among all the patients referring to the ambulatory cardiologists of the healthcare district.

NCT ID: NCT01804816 Completed - Clinical trials for Chronic Heart Failure

Acupuncture on Cardiac and Autonomic Function in Human Heart Failure

Start date: February 2013
Phase: N/A
Study type: Interventional

Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal function. The suppression of inflammatory reaction with acupuncture treatment may also be associated with these outcomes. Specific aims include: 1. To evaluate the effect of acupuncture treatment on human cardiac sympathetic/vagal activity 2. To evaluate the effect of acupuncture treatment on cardiac function and functional capacity 3. To evaluate the general health score of the quality-of-life with acupuncture treatment 4. To explore the mechanism of acupuncture treatment on inflammation and nitrative stress in heart failure patients.

NCT ID: NCT01801722 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease

NT-proBNP
Start date: April 2008
Phase: N/A
Study type: Observational

The aim of the present study was to evaluate if the analysis of NT-proBNP might be used as an initial step for the diagnosis of chronic heart failure in patients with COPD in primary health care, and to select patients for a further examination by echocardiography.

NCT ID: NCT01794598 Terminated - Clinical trials for Chronic Heart Failure

Preliminary Study Examining Heart Failure Patients Responses to Depression Education

Start date: May 2004
Phase: N/A
Study type: Interventional

Purpose of the Study: The significant impact of depression on the poor prognosis and functional restrain, recognition and successful treatment of depression in patients with Chronic Heart Failure (CHF) may result in improvement of overall outcome of those patients. However, depression comorbid with CHF has been overlooked in the real practice. Therefore, the investigators are proposing a study to 1) assess the prognostic impact of depression in patients with stable CHF who have been managed as outpatients, and 2) assess whether provision of depression education to CHF patients will improve the care of depression. Patients with chronic heart failure are enrolled into this study with a half of them are randomly assigned to receive a packet of depression education materials and then other half not. Participants and investigators both are blinded to the assignment. All the participants are provided a toll free phone number to contact the research team as needed. Depressive symptoms and patients knowledge of depression are assessed at baseline prior to randomization and at 1-month and 6-month following the enrollment. Responses of the study participants, such as change of depressive symptoms, and requests for psychiatric help are examined between two groups.